The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events

European Journal of Cancer

Volumn 41, Issue 1, 2005, Pages 168-177

  Lottin, Séverine ^a   Adriaenssens, Eric ^a   Berteaux, Nathalie ^a   Leprêtre, Alain ^b   Vilain, Marie Odile ^c   Denhez, Eve ^a   Coll, Jean ^d   Dugimont, Thierry ^a,e   Curgy, Jean Jacques ^a  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d Inst Biol Molec Inst P   (France)

^e UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Endometrial stroma; Endometrium cancers; H19 gene; Hyperplastic endometrium; Myometrium; Oncogene

Indexed keywords

ADENOMYOSIS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; FEMALE; GENE; GENE OVEREXPRESSION; H19 GENE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RNA SYNTHESIS; STATISTICAL SIGNIFICANCE; UTERUS CARCINOMA;

ADULT; AGED; CELL PROLIFERATION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOMETRIUM; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC; UTERINE NEOPLASMS;

EID: 11144330666     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.09.025     Document Type: Article

References (37)

1. V. Pachnis, A. Belayev, and S.M. Tilghman Locus unlinked to α-fetoprotein under the control of the murine raf and Rif genes Proc Natl Acad Sci USA 81 1984 5523 5527
2. V. Pachnis, C.I. Brannan, and S.M. Tilghman The structure and expression of a novel gene activated in early mouse embryogenesis EMBO J 7 1988 673 681
3. M.P. Leibovitch, V.C. Nguyen, M.S. Gross, B. Solhonne, S.A. Leibovitch, and A. Bernheim The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15 Biochem Biophys Res Commun 180 1991 1241 1250
4. S. Douc-Rasy, J. Coll, M. Barrois, A. Joubel, S. Prost, C. Dozier, D. Sté helin, and G. Riou Expression of the human fetal BAC/H19 gene in invasive cancers Int J Oncol 2 1993 753 758
5. T. Dugimont, J.J. Curgy, N. Wernert, A. Delobelle, M.B. Raes, A. Joubel, D. Stéhelin, and J. Coll The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas Biol Cell 85 1995 117 124
6. I. Ariel, D. Weinstein, R. Voutilainen, T. Schneider, O. Lustig-Yariv, N. De Groot, and A. Hochberg Genomic imprinting and the endometrial cycle: the expression of the imprinting gene H19 in the human female reproductive organs Diagn Mol Pathol 6 1997 17 25
7. E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Leprêtre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.J. Curgy H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression Am J Pathol 53 1998 1597 1607
8. E. Adriaenssens, S. Lottin, T. Dugimont, W. Fauquette, J. Coll, J.P. Dupouy, B. Boilly, and J.J. Curgy Steroid hormones modulate H19 gene expression in both mammary gland and uterus Oncogene 18 1999 4460 4473
9. M.S. Bartolomei, S. Zemel, and S.M. Tilghman Parental imprinting of the mouse H19 gene Nature 351 1991 153 155
10. S. Lottin, N. Berteaux, E. Adriaenssens, T. Dugimont, J. Coll, and J.J. Curgy Expression and function of the H19 gene in normal and tumoral development S.G. Pandalai Recent Res Devel Human Pathol 1 2003 Transworld Res Network Trivandrum-695023, Kerala, India 9 30
11. C.I. Brannan, E.C. Dees, R.S. Ingram, and S.M. Tilghman The product of the H19 gene may function as an RNA Mol Cell Biol 10 1990 28 36
12. A. Joubel, J.J. Curgy, H. Pelczar, A. Bègue, C. Lagrou, D. Stéhelin, and J. Coll The 5′ part of the human H19 RNA contains cis-acting elements hampering its translatability Cell Mol Biol 42 1996 1159 1172
13. Y. Hao, T. Crenshaw, T. Moulton, E. Newcomb, and B. Tycko RNA Tumor-suppressor activity of H19 RNA Nature 365 1993 764 767
14. L.H. Reid, A. West, D.G. Gioeli, K.K. Phillips, K.F. Kelleher, D. Araujo, E.J. Stanbridge, S.F. Dowdy, D.S. Gerhard, and B.E. Weissman Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay Hum Mol Genet 5 1996 239 247
15. R.J. Isfort, G.A. Kerckaert, B. Tycko, and R.A. Le Boeuf Role of the H19 gene in Syrian hamster embryo cell tumorigenicity Mol Carcinogen 20 1997 189 193
16. P. Ohana, E. Kopf, O. Bibi, S. Ayesh, T. Schneider, M. Laster, M. Tykocinski, N. De Groot, and A. Hochberg The expression of the H19 gene and its function in human bladder carcinoma cell lines FEBS Lett 454 1999 81 84
17. L.H.J. Looijenga, A.J.M.H. Verkerk, N. De Groot, A.A. Hochberg, and J.W. Oosterhuis H19 in normal development and neoplasia Mol Reprod Dev 46 1997 419 439
18. I. Ariel, O. Lustig, T. Schneider, G. Pizov, M. Sappir, N. De Groot, and A. Hochberg The imprinted H19 gene as a tumor marker in bladder carcinoma Urology 45 1995 335 338
19. Y.M. Li, G. Franklin, H.M. Cui, K. Svensson, X.B. He, G. Adam, R. Ohlsson, and S. Pfeifer The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans J Biol Chem 273 1998 28247 28252
20. S. Lottin, E. Adriaenssens, T. Dupressoir, N. Berteaux, C. Montpellier, J. Coll, T. Dugimont, and J.J. Curgy Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells Carcinogenesis 23 2002 1885 1895
21. S. Lottin, A.S. Vercoutter-Edouart, E. Adriaenssens, X. Czeszak, J. Lemoine, M. Roudbaraki, J. Coll, H. Hondermarck, T. Dugimont, and J.J. Curgy Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA Oncogene 21 2002 1625 1631
22. D. Lustig, I. Ariel, J. Ilan, E. Lev-Lehman, N. De Groot, and A. Hochberg Expression of the imprinted gene H19 in the human fetus Mol Reprod Dev 38 1994 239 246
23. A.J. Balaton, F. Ochando, and M.H. Painchaud Utilisation des micro-ondes pour activer ou restaurer les antigènes avant la réaction immunohistochimique Ann Pathol 13 1993 188 189
24. C. Quéva, S.A. Ness, T. Graf, F.A. Grässer, B. Vanderbunder, and D. Stéhelin Expression patterns of c-myb and v-myb induced myeloid-1 (mim-1) gene during the development of the chick embryo Development 114 1992 125 133
25. E. Adriaenssens, S. Lottin, N. Berteaux, L. Hornez, W. Fauquette, V. Fafeur, J.P. Peyrat, X. Le Bourhis, H. Hondermarck, J. Coll, T. Dugimont, and J.J. Curgy Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells Exp Cell Res 275 2002 215 229
26. T. Moulton, T. Crenshaw, Y. Hao, J. Moosikasuwan, N. Lin, F. Dembitzer, T. Hensle, L. Weiss, L. McMorrow, T. Loew, W. Kraus, W. Gerald, and B. Tycko Epigenetic lesions at the H19 locus in Wilms' tumour patients Nature Genet 7 1994 440 447
27. M.J. Steeman, S. Rainier, C.J. Dobry, P. Grundy, I.L. Horon, and A.P. Feinberg Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour Nature Genet 7 1994 433 439
28. T. Taniguchi, M.J. Sullivan, O. Ogawa, and A.E. Reeve Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms'tumor Proc Natl Acad Sci USA 92 1995 2159 2163
29. S. Douc-Rasy, M. Barrois, S. Fogel, J.C. Ahomadegbe, D. Stéhelin, J. Coll, and G. Riou High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19 Oncogene 12 1996 423 430
30. I. Ariel, H.Q. Miao, X. Ji, T. Schneider, D. Roll, N. de Groot, A. Hochberg, and S. Ayesh Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma J Clin Pathol Mol Pathol 51 1998 21 25
31. L. Adam, M. Crépin, J.C. Lelong, E. Spanakis, and L. Israel Selective interactions between mammary epithelial cells and fibroblasts in co-culture Int J Cancer 59 1994 262 268
32. E. Spanakis, and D. Brouty-Boyé Discrimination of fibroblast subtypes by multivariate analysis of gene expression Int J Cancer 71 1997 402 409
33. C. Singer, A. Rasmussen, H.S. Smith, M.E. Lippman, H.T. Lynch, and J. Cullen Malignant breastepithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function Cancer Res 55 1995 2448 2454
34. K. Hashimoto, C. Azuma, and Y. Tokugawa Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed Müllerian tumor of the uterus Hum Pathol 28 1997 862 865
35. T. Dugimont, C. Montpellier, E. Adriaenssens, S. Lottin, L. Dumont, V. Iotsova, C. Lagrou, D. Stéhelin, J. Coll, and J.J. Curgy The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 Oncogene 16 1998 2395 2401
36. C.S. Wang, and B. Tetu Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction Int J Cancer 99 2002 792 799
37. M.M. Mueller, and N.E. Fusenig Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells Differentiation 70 2002 486 497